文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

调节性 T 细胞的募集与低氧诱导的 CXCR4 表达相关,并且与基底样乳腺癌的不良预后相关。

Recruitment of regulatory T cells is correlated with hypoxia-induced CXCR4 expression, and is associated with poor prognosis in basal-like breast cancers.

机构信息

Department of Pathology, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Melbourne, VIC 3002, Australia.

出版信息

Breast Cancer Res. 2011 Apr 26;13(2):R47. doi: 10.1186/bcr2869.


DOI:10.1186/bcr2869
PMID:21521526
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3219210/
Abstract

INTRODUCTION: Basal-like breast cancers behave more aggressively despite the presence of a dense lymphoid infiltrate. We hypothesised that immune suppression in this subtype may be due to T regulatory cells (Treg) recruitment driven by hypoxia-induced up-regulation of CXCR4 in Treg. METHODS: Immunoperoxidase staining for FOXP3 and CXCL12 was performed on tissue microarrays from 491 breast cancers. The hypoxia-associated marker carbonic anhydrase IX (CA9) and double FOXP3/CXCR4 staining were performed on sections from a subset of these cancers including 10 basal-like and 11 luminal cancers matched for tumour grade. RESULTS: High Treg infiltration correlated with tumour CXCL12 positivity (OR 1.89, 95% CI 1.22 to 2.94, P = 0.004) and basal phenotype (OR 3.14, 95% CI 1.08 to 9.17, P = 0.004) in univariate and multivariate analyses. CXCL12 positivity correlated with improved survival (P = 0.005), whereas high Treg correlated with shorter survival for all breast cancers (P = 0.001), luminal cancers (P < 0.001) and basal-like cancers (P = 0.040) that were confirmed in a multivariate analysis (OR 1.61, 95% CI 1.02 to 2.53, P = 0.042). In patients treated with hormone therapy, high Treg were associated with a shorter survival in a multivariate analysis (OR 1.78, 95% CI 1.01 to 3.15, P = 0.040). There was a tendency for luminal cancers to show CXCL12 expression (102/138, 74%) compared to basal-like cancers (16/27, 59%), which verged on statistical significance (P = 0.050). Up-regulation of CXCR4 in Treg correlated with the basal-like phenotype (P = 0.029) and tumour hypoxia, as indicated by CA9 expression (P = 0.049). CONCLUSIONS: Our data show that in the setting of hypoxia and CXCR4 up-regulation in Treg, CXCL12 expression may have the negative consequence of enhancing Treg recruitment and suppressing the anti-tumour immune response.

摘要

简介:尽管存在致密的淋巴浸润,基底样乳腺癌的侵袭性更强。我们假设这种亚型的免疫抑制可能是由于缺氧诱导 Treg 中 CXCR4 的上调导致 T 调节细胞(Treg)募集所致。

方法:对 491 例乳腺癌组织微阵列进行 FOXP3 和 CXCL12 的免疫过氧化物酶染色。对这些癌症的一部分进行了缺氧相关标志物碳酸酐酶 IX(CA9)和双 FOXP3/CXCR4 染色,包括 10 例基底样和 11 例管腔癌,肿瘤分级相匹配。

结果:高 Treg 浸润与肿瘤 CXCL12 阳性(OR 1.89,95%CI 1.22-2.94,P = 0.004)和基底表型(OR 3.14,95%CI 1.08-9.17,P = 0.004)相关,在单变量和多变量分析中均为阳性。CXCL12 阳性与生存改善相关(P = 0.005),而高 Treg 与所有乳腺癌(P = 0.001)、管腔癌(P < 0.001)和基底样癌(P = 0.040)的生存时间较短相关,这在多变量分析中得到证实(OR 1.61,95%CI 1.02-2.53,P = 0.042)。在接受激素治疗的患者中,高 Treg 与多变量分析中的生存时间较短相关(OR 1.78,95%CI 1.01-3.15,P = 0.040)。与基底样癌(16/27,59%)相比,管腔癌更倾向于显示 CXCL12 表达(102/138,74%),这接近统计学意义(P = 0.050)。Treg 中 CXCR4 的上调与基底样表型相关(P = 0.029),并与肿瘤缺氧相关,如 CA9 表达所示(P = 0.049)。

结论:我们的数据表明,在缺氧和 Treg 中 CXCR4 上调的情况下,CXCL12 的表达可能会通过增强 Treg 的募集并抑制抗肿瘤免疫反应而产生负面影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/518a/3219210/d6143859882a/bcr2869-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/518a/3219210/82671d36127f/bcr2869-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/518a/3219210/09bb247e39ba/bcr2869-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/518a/3219210/d6143859882a/bcr2869-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/518a/3219210/82671d36127f/bcr2869-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/518a/3219210/09bb247e39ba/bcr2869-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/518a/3219210/d6143859882a/bcr2869-3.jpg

相似文献

[1]
Recruitment of regulatory T cells is correlated with hypoxia-induced CXCR4 expression, and is associated with poor prognosis in basal-like breast cancers.

Breast Cancer Res. 2011-4-26

[2]
The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy.

Br J Cancer. 2009-1-27

[3]
The basal-like breast carcinoma phenotype is regulated by SLUG gene expression.

J Pathol. 2008-1

[4]
Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer.

Br J Cancer. 2007-1-15

[5]
CA IX is an independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph nodes and a putative marker of radiation resistance.

Clin Cancer Res. 2006-11-1

[6]
The presence of a fibrotic focus in invasive breast carcinoma correlates with the expression of carbonic anhydrase IX and is a marker of hypoxia and poor prognosis.

Breast Cancer Res Treat. 2003-9

[7]
Co-expression of VEGF and CA9 in ovarian high-grade serous carcinoma and relationship to survival.

Virchows Arch. 2012-6-15

[8]
Carbonic anhydrase 9 is associated with chemosensitivity and prognosis in breast cancer patients treated with taxane and anthracycline.

BMC Cancer. 2014-6-4

[9]
Regulatory T lymphocyte infiltration in metastatic breast cancer-an independent prognostic factor that changes with tumor progression.

Breast Cancer Res. 2021-2-18

[10]
Nodal status in luminal A invasive breast cancer: relationships with cytotoxic CD8 + and regulatory FOXP3 + cells tumor-associated infiltrate and other prognostic factors.

Virchows Arch. 2021-11

引用本文的文献

[1]
Hypoxic link between cancer cells and the immune system: The role of adenosine and lactate.

Oncol Res. 2025-7-18

[2]
Cancer-associated fibroblasts in cancer drug resistance and cancer progression: a review.

Cell Death Discov. 2025-7-24

[3]
Tumor hypoxia shapes natural killer cell anticancer activities.

J Mol Med (Berl). 2025-5-30

[4]
Immune evasion mechanisms in early-stage I high-grade serous ovarian carcinoma: insights into regulatory T cell dynamics.

Cell Death Dis. 2025-4-1

[5]
Preliminary characterisation of the spatial immune and vascular environment in triple negative basal breast carcinomas using multiplex fluorescent immunohistochemistry.

PLoS One. 2025-1-10

[6]
Knowledge landscape of Treg research in breast cancer: a bibliometric and visual analysis.

Front Oncol. 2024-11-27

[7]
Understanding the role of TNFR2 signaling in the tumor microenvironment of breast cancer.

J Exp Clin Cancer Res. 2024-11-28

[8]
Complex Role of Regulatory T Cells (Tregs) in the Tumor Microenvironment: Their Molecular Mechanisms and Bidirectional Effects on Cancer Progression.

Int J Mol Sci. 2024-7-4

[9]
Hypoxia-inducible factor in breast cancer: role and target for breast cancer treatment.

Front Immunol. 2024

[10]
Targeting CXCR4 impaired T regulatory function through PTEN in renal cancer patients.

Br J Cancer. 2024-6

本文引用的文献

[1]
Immune regulation of cancer.

J Clin Oncol. 2010-6-1

[2]
Enrichment of CCR6+Foxp3+ regulatory T cells in the tumor mass correlates with impaired CD8+ T cell function and poor prognosis of breast cancer.

Clin Immunol. 2010-2-24

[3]
Induction of HIF-1alpha and the glycolytic pathway alters apoptotic and differentiation profiles of activated human T cells.

J Leukoc Biol. 2009-11-5

[4]
Enhancing cancer vaccine efficacy via modulation of the tumor microenvironment.

Clin Cancer Res. 2009-11-1

[5]
Correlation of CXCL12 expression and FoxP3+ cell infiltration with human papillomavirus infection and clinicopathological progression of cervical cancer.

Am J Pathol. 2009-10

[6]
Concurrent trastuzumab and HER2/neu-specific vaccination in patients with metastatic breast cancer.

J Clin Oncol. 2009-10-1

[7]
Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel.

J Clin Oncol. 2009-10-1

[8]
CXCR4 expression functionally discriminates centroblasts versus centrocytes within human germinal center B cells.

J Immunol. 2009-6-15

[9]
T-regulatory cell modulation: the future of cancer immunotherapy?

Br J Cancer. 2009-6-2

[10]
CXCR4+FOXP3+CD25+ lymphocytes accumulate in CXCL12-expressing malignant pleural mesothelioma.

Int J Immunopathol Pharmacol. 2009

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索